Abstract
All activities involving the use of ionizing radiation are conducted in accordance with the regulations and guidelines established by regulatory authorities. In our country, Nuclear Medicine practices are carried out under a license issued by the Nuclear Regulatory Authority. Globally, the rules for protection against ionizing radiation are determined by the International Commission on Radiological Protection and are communicated to member countries as advisory guidelines. Radiation protection regulations are categorized separately for personnel and patients. In this article, radiation protection rules are reported in two separate categories for staff and patients.
Keywords: Radioactive treatment, 131-I, radiation protection, effective dose, contamination
References
EANM radionuclide metabolic therapyclinical aspects, dosimetry and imaging, a technologist’s guide. Section I: special considerations in radiation protection, p. 41.
Khalil M, ed. Basic sciences of nuclear medicine, 1st edn. New York: Springer; 2011.
Draft Euratom Basic Safety Standard Directive, 2010. Available link: https://energy.ec.europa.eu/system/files/2015-11/2010_02_24_draft_euratom_basic_safety_standards_directive_0.pdf
ICRP Publication 103. Available link: https://www.icrp.org/publication.asp?id=ICRP%20Publication%20103
ICRP Publication 94. Available link: https://www.icrp.org/publication.asp?id=ICRP%20Publication%2094
Council Directive 97/43 Euratom. 1997. Available link: https://eur-lex.europa.eu/eli/dir/1997/43/oj/eng
Radyasyon güvenliği yönetmeliğinde değişiklik yapılmasına dair yönetmelik (29 Eylül 2004 tarih ve 25598 sayı).
Harding LK. Radiation protection legislation. Eur J Nucl Med. 1998;25:187-191.
Radyoloji Hizmetleri Yönetmeliği (26 Nisan 2022 tarih ve 31821 sayı).
Radyasyon Güvenliği Yönetmeliği (24.03.2000 tarih ve 23999 sayı).
Sağlık hizmetlerinde iyonlaştırıcı radyasyon kaynakları ile çalışan personelin radyasyon doz limitleri ve çalışma esasları hakkında yönetmelik (2012 tarih ve 28344 sayı).
Huggett S, ed. Best practice in nuclear medicine. Part 2. A technologist’s guide. Vienna: European Association of Nuclear Medicine; 2007.
ICRP publication 84. Available link: https://www.icrp.org/publication.asp?id=icrp%20publication%2084
Release of patients after radionuclide therapy IAEA BSS 63. Available link: https://www-pub.iaea.org/MTCD/Publications/PDF/pub1417_web.pdf
International commission on radiological protection, doses to infants from ingestion of radionuclides in mothers’ milk, Publication 2024;95.
Salvatori M, Lucignani G. Radiation exposure, protection and risk from nuclear medicine procedures. Eur J Nucl Med. 2010;37:1225-1231.
European Commission. Radiation protection following iodine-131 therapy (exposure due to out-patients or discharged in-patients), 1998.
Hyer SL, Pratt B, Newbold K, Hamer CL. Outcome of pregnancy after exposure to radioiodine in utero. Endocr Pract. 2011;17:1-10.
Radyasyon güvenliği yönetmeliğinde değişiklik yapılmasına dair yönetmelik (29 Eylül 2004 tarih ve 25598 sayı).
